Inhibrx Inc
NASDAQ:INBX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inhibrx Inc
NASDAQ:INBX
|
US |
|
T
|
Thai Beverage PCL
XMUN:T6W
|
TH |
|
Eastern Bankshares Inc
F:EB0
|
US |
|
C
|
China State Construction International Holdings Ltd
XMUN:C4S1
|
HK |
|
R
|
Realtech AG
SWB:RTC
|
DE |
|
Mcphy Energy SA
F:M6P
|
FR |
|
T
|
Terracom Ltd
ASX:TER
|
AU |
|
M
|
Minor International PCL
SET:MINT
|
TH |
|
Blue Sky Uranium Corp
XTSX:BSK
|
CA |
|
Spirax-Sarco Engineering PLC
LSE:SPX
|
UK |
|
Telecom Egypt Co SAE
LSE:TEEG
|
EG |
|
V
|
Virtus Investment Partners Inc
F:VIP
|
US |
|
Immunovant Inc
NASDAQ:IMVT
|
US |
|
L
|
Link Mobility Group Holding ASA
OSE:LINK
|
NO |
|
U
|
United Labels AG
XHAM:ULC
|
DE |
Wall St Price Targets
INBX Price Targets Summary
Inhibrx Inc
According to Wall Street analysts, the average 1-year price target for
INBX is 283.05 USD with a low forecast of 232.3 USD and a high forecast of 341.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INBX's stock price target?
Price Target
283.05
USD
According to Wall Street analysts, the average 1-year price target for
INBX is 283.05 USD with a low forecast of 232.3 USD and a high forecast of 341.25 USD.
What is the Revenue forecast for Inhibrx Inc?
Projected CAGR
153%
Over the last 7 years, the compound annual growth rate for Revenue has been -24%. The projected CAGR for the next 8 years is 153%.